Nuclear Energy Market Roundup
2/28/26
SEQH Capital Research
Nuclear Energy Market Roundup
Tear Sheet – Week Ending February 27, 2026
Why This Report Exists
This weekly roundup synthesizes the most critical developments across the nuclear and uranium sectors, from spot price movements and earnings season results to policy shifts and company announcements. The week of February 20–27 saw bearish near-term price action as uranium pulled back from January highs, but structural catalysts remain firmly intact. This report provides investors with a comprehensive view of what moved markets and what’s coming next.
Market Snapshot
Uranium pricing:
Spot uranium: 86.55 dollars per lb on February 27, down ~1.7% on the day and ~3.4% over trailing month.
Still 34% above year-ago levels.
Pullback follows January’s explosive 24% rally to 101.26 dollars per lb (highest since 107 dollars in February 2024), driven by Section 232 national security designation.
Long-term contract prices held firm at 90 dollars per lb per TradeTech.
Weekly stock performance winners:
Constellation Energy (CEG): +11.88% on Calpine acquisition close and expanded data center deals.
Nano Nuclear (NNE): Rallied on UAE MOU.
Bloom Energy (BE): Continued post-earnings momentum.
Weekly laggards:
Uranium Energy Corp (UEC): Dilution concerns from ESOP shelf registration.
NuScale (SMR): -4.39%, massive Q4 earnings miss.
Cameco (CCJ): Drifted on uranium price pullback.
Earnings Season Recap: Winners and Losers
Constellation Energy (CEG), Strong Quarter + Transformational Acquisition:
Q4 2025 adjusted operating earnings: 2.00 dollars per share, full-year 9.39 dollars per share.
Completed Calpine Corporation acquisition February 20, creating nation’s largest electricity producer with 55 GW combined capacity serving 2.5 million customers including three-fourths of Fortune 100.
Secured 380 MW power deal with CyrusOne in Texas (total CyrusOne commitments now above 1,100 MW).
Received 1B dollar DOE loan guarantee to restart Crane Clean Energy Center (TMI-1), supported by 20-year PPA with Microsoft.
Clinton and Dresden nuclear plants received 20-year license extensions.
BWX Technologies (BWXT), Record Year + Backlog Surges 50%:
Q4 EPS: 1.08 dollars vs. 0.91 consensus, revenue 885.8M representing 18.7% YoY growth.
Full-year 2025 sales: 3.20B dollars with net income of 328.95M.
Backlog reached 7.3B dollars, a 50% increase YoY, driven by multi-year naval propulsion contracts, defense enrichment work, and expanding commercial nuclear engagements.
2026 guidance: revenue ~3.75B, non-GAAP EPS 4.55–4.70, adjusted EBITDA 645–670M, FCF 305–320M.
8% dividend increase.
NuScale Power (SMR), Massive Q4 Miss:
Q4 EPS: (0.80) vs. (0.10) consensus, revenue 1.81M vs. 8.76M expected (dramatic miss).
Full-year revenue 31.5M declined from 37.0M in 2024.
Operational narrative remains compelling: NRC approved 77 MW standard design ahead of schedule (only SMR certified under 10 CFR Part 52), ENTRA1/TVA progressing toward potential 6 GW deployment, 12 modules in production at Doosan.
Ended 2025 with ~1.3B in liquidity.
Miss triggered securities class action (deadline April 20, 2026).
Energy Fuels (UUUU), Production Beats + Losses Widen:
Q4 EPS: (0.12) vs. (0.07) consensus, revenue 27.1M (slight beat).
Full-year 2025: mined 1.72M lbs U3O8 (exceeding guidance), processed 1.015M+ lbs finished product, sold 650K lbs at weighted average 74.21 dollars per lb for 48.2M uranium revenue.
Working capital: 927.4M following 700M convertible notes offering.
Net loss widened to 86.1M from 47.8M, driven by higher SG&A from Base Resources acquisition, elevated exploration spending, Madagascar charges.
Two new long-term contracts extend deliveries through 2032, REE project NPVs totaling 3.7B across Phase 2 Circuit and Vara Mada.
Bloom Energy (BE), Blowout Quarter:
Q4 EPS: 0.45 vs. 0.25 consensus (+80% surprise), revenue 777.68M vs. 649M expected (35.9% YoY growth).
Four consecutive quarters of beating both EPS and revenue.
Shares rallied ~69.6% YTD vs. S&P 500’s 0.5%.
Centrus Energy (LEU), Q4 Miss:
Q4 EPS: 0.79 vs. 1.42 consensus, revenue 146.2M (miss), declining 3.5% YoY.
Full-year 2025 revenue 448.7M grew 1.5% with net income 77.8M (+6% YoY).
Contracted backlog: 3.6B provides long-term revenue visibility.
Stock declined over 21% YTD following miss.
Policy & Regulatory Developments
NRC Licenses TRISO-X, First New Fuel Facility in 50+ Years:
NRC issued Special Nuclear Material License to TRISO-X LLC (X-energy subsidiary) for commercial HALEU fuel manufacture at TX-1 and TX-2 facilities, 40-year license.
First new fuel fabrication facility licensed by NRC in over 50 years, first-ever Category II nuclear fuel facility in U.S.
TX-1 under construction at Oak Ridge, Tennessee, capacity for 5 tonnes uranium (700,000 TRISO pebbles per year), enough to fuel up to 11 Xe-100 SMRs.
Approval came three months ahead of schedule, directly de-risks HALEU fuel supply chain.
State-level nuclear push accelerates:
Over 15 states introduced nuclear-friendly legislation in 2026 alone.
Other key developments:
NRC launched 90-day public comment period on fusion regulatory framework.
DOE released previously secret rules slashing environmental and security requirements for experimental reactors to meet Trump executive order calling for 3+ reactors to reach criticality by July 4, 2026.
NRC accepted license amendment requests for TMI-1 restart.
Pentagon and DOE successfully airlifted compact nuclear reactor from California to Utah (first such demonstration).
Company & Deal Flow Updates
Denison Mines (DNN): Reached Final Investment Decision on Phoenix In-Situ Recovery uranium mine, targeting first production mid-2028.
Nano Nuclear (NNE): Signed MOU with EHC Investment of Abu Dhabi to explore JV for micro modular reactors in UAE and Gulf markets.
ASP Isotopes (ASPI): CEO outlined aggressive 2026 commercialization roadmap including silicon-28 shipments in H1, ytterbium-176 scaling, carbon-14 revenue in Q2. QLE spin-off executed services contract with South Africa’s Necsa for HALEU enrichment facility.
Oklo (OKLO): Pipeline now at ~14 GW of committed and LOI agreements including 12 GW with Switch and 1.2 GW with Meta.
Vistra Corp (VST) & Talen Energy (TLN): Data center thesis continues driving performance, Vistra guiding to 22% EBITDA jump in 2026.
Uranium Energy Corp (UEC): Filed 90.24M shelf registration for ESOP, adding to dilution concerns.
Holtec/Palisades: Restart facing delays due to missing documentation.
Sector Thesis & Risk Monitor
Bull Case (8.3/10 conviction):
AI data center power requirements projected to double or triple by 2028, with individual facilities now drawing 1+ GW.
Hyperscalers (Amazon, Microsoft, Meta, Google) bypassing traditional utility queues with direct behind-the-meter nuclear deals.
Section 232 national security designation for uranium opens door to price floors, import curbs, government equity stakes in domestic producers.
Global uranium supply remains structurally constrained, utility contracting deficits described as “coiled spring.”
Bear Case (7.8/10):
Valuation compression risk across advanced reactor sub-sector, pre-revenue names like Oklo trade at 9x book (vs. 1.8x peer average).
NuScale’s 3.8B market cap sits atop just 31.5M declining annual revenue.
DOE slashing environmental and security reviews to meet July 4 deadline raises safety concerns that could generate political backlash.
Uranium spot pulled back nearly 15% from January highs to 86.55.
Uzbekistan’s production surge to 7,000 tonnes signals supply may respond faster than bulls anticipate.
Execution risk across SMR/advanced reactor complex remains acute, no commercial-scale advanced reactor built in U.S.
Net assessment: Bull case conviction outweighs bear, structural thesis intact.
Key Risk Flags
[HIGH] SMR securities class action filed (deadline April 20, 2026).
[HIGH] No binding PPAs across all advanced reactor developers.
[MED] Uranium spot -15% from January highs (86.55 vs. 101.24 peak).
[MED] UEC S-3ASR shelf registration (90.24M dilution overhang).
[MED] Palisades restart documentation hurdle (CNWRA missing).
Upcoming Catalysts (March-December 2026)
High-impact events:
March 8: DNN Phoenix ISR construction begins (impact: 9/10).
H1 2026: ASPI silicon-28 commercial shipments begin (impact: 8/10).
July 4: DOE 2+ experimental reactors reach criticality (impact: 9/10).
July 2026: OKLO Atomic Alchemy rad-isotope ops launch (impact: 8/10).
2026 ongoing: Palisades fuel loading and restart (impact: 8/10).
2026 ongoing: ENTRA/TVA PPA binding contract progress (impact: 10/10).
SEQH View
The week’s bearish price action reflects near-term consolidation after January’s explosive rally, not a breakdown of the structural thesis. Uranium at 86.55 dollars per lb is still 34% above year-ago levels with long-term contracts firm at 90 dollars per lb. Earnings season revealed a bifurcated sector: established players like Constellation and BWXT are executing at scale with massive backlogs and transformational acquisitions, while pre-commercial names like NuScale face execution and valuation risk. The NRC’s licensing of TRISO-X is a watershed moment for HALEU supply, and state-level policy momentum continues to accelerate. We maintain a bullish medium-term view but acknowledge elevated valuation risk in the advanced reactor sub-sector.
Want the Full Weekly Market Roundup?
[READ THE COMPLETE NUCLEAR ENERGY MARKET ROUNDUP]
The full report includes comprehensive sector coverage unavailable elsewhere:
Complete SEQH coverage universe weekly performance breakdown with market cap and YTD return tracking
Detailed earnings season forensics for all major nuclear and uranium names (CEG, BWXT, SMR, UUUU, BE, LEU)
Full policy and regulatory developments analysis including NRC TRISO-X licensing implications and state-level legislative tracking
Company-by-company deal flow and partnership updates across advanced reactor, fuel cycle, and uranium mining segments
Sector thesis monitor with bull case (8.3/10) vs. bear case (7.8/10) conviction scoring
Risk matrix with HIGH/MED/LOW flagging across securities litigation, PPA conversion, spot price, dilution, and execution risks
Catalyst calendar with impact scoring (1–10) for March through December 2026 events
Uranium producer margin analysis at current 86.55 spot pricing
Dilution risk monitor across SEQH coverage universe
Regulatory and FOAK timeline analysis (years to first commercial power)
The nuclear energy renaissance is accelerating, but so is execution risk. This weekly roundup gives you the data to navigate both.
Available exclusively to SEQH Capital Research paid subscribers. Upgrade to access →
